Altimmune (ALT) Receivables (2016 - 2025)
Historic Receivables for Altimmune (ALT) over the last 17 years, with Q3 2025 value amounting to $1.5 million.
- Altimmune's Receivables rose 11222.53% to $1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 million, marking a year-over-year increase of 11222.53%. This contributed to the annual value of $944000.0 for FY2024, which is 2204.79% down from last year.
- Per Altimmune's latest filing, its Receivables stood at $1.5 million for Q3 2025, which was up 11222.53% from $321000.0 recorded in Q2 2025.
- Altimmune's 5-year Receivables high stood at $4.8 million for Q1 2021, and its period low was $136000.0 during Q2 2023.
- For the 5-year period, Altimmune's Receivables averaged around $1.1 million, with its median value being $724000.0 (2024).
- In the last 5 years, Altimmune's Receivables tumbled by 9598.04% in 2022 and then surged by 60000.0% in 2023.
- Altimmune's Receivables (Quarter) stood at $429000.0 in 2021, then crashed by 59.67% to $173000.0 in 2022, then skyrocketed by 600.0% to $1.2 million in 2023, then fell by 22.05% to $944000.0 in 2024, then skyrocketed by 63.67% to $1.5 million in 2025.
- Its Receivables was $1.5 million in Q3 2025, compared to $321000.0 in Q2 2025 and $907000.0 in Q1 2025.